43 articles tagged with "healthcare"
A small biotech firm has ceased operations following a significant delay in securing FDA approval for its clinical trial plan, highlighting the critical nature of regulatory timelines.
The upcoming reform in state medical insurance will implement digital referrals and establish a national health insurance fund, aiming to enhance healthcare access and efficiency.
Smaller biotech firms are initiating discussions with the Trump administration as the sector experiences notable mergers and acquisitions, while addressing trust issues in healthcare.
The FDA has approved Foundayo, a daily oral medication for obesity management, which will compete with the injectable Wegovy. This approval was expedited by the agency.
A recent study across five academic medical centers indicates that AI scribes can save doctors about 16 minutes during an eight-hour shift, though usage remains inconsistent.
Eli Lilly's leadership has expressed clear opposition to the White House's initiative to codify drug pricing reforms, particularly the 'most favored nation' proposal.
Johnson & Johnson (JNJ) demonstrates a strong growth pipeline and solid performance across key therapeutic areas, indicating a positive trajectory for future revenue.
Current market analysis indicates a cautious outlook on Omega Healthcare Investors, Inc. (OHI) due to concerns over financial stability and disappointing earnings.
Doctors Without Borders has criticized Gilead Sciences for declining to provide lenacapavir, a crucial HIV prevention drug, after lengthy negotiations.
The introduction of AI-driven health applications by major players like Microsoft and Amazon prompts a critical examination of their operational efficacy and integration within existing healthcare systems.
The legal euthanasia of a 25-year-old woman in Spain underscores the complexities of healthcare systems and legal frameworks surrounding end-of-life decisions.
Recent findings highlight that the shape of DNA significantly influences the precision of CRISPR gene editing, presenting challenges for therapeutic applications.
The FDA's approval of Denali Medicine's treatment for Hunter syndrome indicates a pivotal moment in the regulatory landscape for rare disease therapies, amidst heightened scrutiny.
Eli Lilly underscores the critical role of GLP-1 medications in healthcare, while also noting Merck's acquisition of Terns Pharma and other biotech advancements.
The FTC's proposed settlement with CVS aims to address allegations of price manipulation by its pharmacy benefit manager, potentially saving consumers $7 billion over the next decade.
An analysis indicates that drugmakers penalized for kickbacks paid only 2.2% of their U.S. revenue from the implicated drugs over the past 25 years.
Research indicates that the addition of 1,000 immigrants, including 142 health care workers, can lead to a notable decrease in elderly mortality rates in metropolitan areas.
Researchers from Scotland and Japan have developed a superconducting chip that generates tunable terahertz waves, enhancing imaging capabilities through various materials, with significant implications for healthcare and security.
A new strategy aims to combat antibiotic resistance by targeting bacterial communication pathways rather than directly eliminating bacteria, potentially enhancing treatment longevity.
Epic's recent lawsuit reveals significant vulnerabilities in the patient record sharing ecosystem, prompting calls for HHS to enhance regulatory oversight.
A mother's experience in obtaining a fecal transplant for her son suffering from a severe C. diff infection underscores the complexities of healthcare access and treatment implementation.
The tripling of sepsis hospitalizations in Massachusetts since 2010 raises critical questions about healthcare billing practices and the integration of AI in medical coding.
In a recent debate at the Euronews Health Summit, MEPs discussed the critical issue of funding for health innovation in Europe, highlighting differing perspectives on healthcare as a right versus a business model.
A proposed bill in Maryland mandates that pharmaceutical companies and patient organizations disclose their affiliations with disease awareness campaigns, aiming to improve transparency.
An Australian entrepreneur claims AI played a role in his dog's cancer treatment, raising significant questions about technology's application in healthcare.
A newly developed AI model analyzes chemical interactions with gene expression, offering significant implications for drug discovery and healthcare.
NIH Director Jay Bhattacharya has assured House appropriators that the agency plans to fully utilize its budget by the conclusion of fiscal year 2026.
The White House is increasing its efforts to secure drug pricing reforms in Congress, focusing on a 'most-favored nation' policy that could reshape pharmaceutical pricing structures.
The recent price hikes by GSK on asthma inhalers have led to significant financial burdens and treatment accessibility issues for patients, as highlighted by a senator's report.
The Centers for Medicare & Medicaid Services (CMS) has introduced a strategy to pause or withhold federal funding in cases of suspected fraud, impacting state budgets and Medicaid enrollees.
The Centers for Medicare & Medicaid Services (CMS) has introduced a strategy to pause federal funding in suspected fraud cases, potentially impacting state budgets and Medicaid enrollees.
Recent polling indicates a significant increase in public anxiety regarding prescription drug costs, with bipartisan support for government intervention in pricing regulation.
The FDA's increased scrutiny on telehealth marketing for GLP-1 drugs could reshape prescribing practices and impact telehealth companies.
A recent study reveals that a modified nanogel could significantly improve the viability of therapeutic stem cells, addressing challenges faced by patients with swallowing difficulties.
Senator Ron Johnson is scrutinizing the FDA's rejection of treatments for rare diseases, following a discussion with Commissioner Marty Makary that raised significant concerns.
The co-founders of BioNTech are leaving to establish a new mRNA-focused company, prompting a U.S. senator to investigate the FDA's oversight.
The FDA's approval of Opill as the first OTC oral contraceptive represents a pivotal shift in contraceptive access, impacting healthcare infrastructure and distribution channels.
A recent study published in Health Affairs indicates that a significant number of family physicians choose to practice in the states where they were trained, impacting healthcare access.
A recent study spanning from 2012 to 2022 highlights significant trends in the mental health and job satisfaction of primary care physicians in the US and nine comparator countries.
A recent study in Health Affairs highlights the dual trends in primary care practices influenced by private equity, showing modest clinician growth alongside rising exits.
A recent study in Health Affairs reveals heightened mortality rates among SSDI beneficiaries during the two-year wait for Medicare coverage from 2000 to 2021.
A study published in Health Affairs analyzes the influence of labor unions on nurse staffing ratios and quality of care in US nursing homes from 2013 to 2021.
The World Health Organization has verified 13 attacks on health sites in Iran, raising concerns about the safety of healthcare infrastructure in conflict zones.